stella
beta
Tislelizumab in Combination With GP or TPC Regimen for the Treatment of Nasopharyngeal Carcinoma With Bone Metastasis. — Stella
Home
/
Nasopharyngeal Carcinoma
/
View on ClinicalTrials.gov
Recruiting
Back to Nasopharyngeal Carcinoma trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(1 site)
China
SunYat-senU, Guangzhou, Guangdong